Skip to content
10-K

Annual Report

PSYCHEMEDICS CORPORATION

0001171843-24-001671

← back to feed
Filed
Mar 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 25, 2024 5.81M sh
Long Term Debt FY 2023 · Dec 31, 2023 $0
Long Term Debt FY 2023 · Dec 31, 2022 $305K
Shares Diluted FY 2023 · Dec 31, 2022 5.63M sh
Dividends Paid FY 2023 · Dec 31, 2022 $1.19M
Capex FY 2023 · Dec 31, 2022 $187K
Operating Cash Flow FY 2023 · Dec 31, 2022 $4.89M
Short Term Debt FY 2023 · Dec 31, 2022 $294K
Cash And Equivalents FY 2023 · Dec 31, 2022 $4.75M
Current Liabilities FY 2023 · Dec 31, 2022 $5.72M
Total Liabilities FY 2023 · Dec 31, 2022 $7.96M
Current Assets FY 2023 · Dec 31, 2022 $9.96M
Total Assets FY 2023 · Dec 31, 2022 $18.73M
Eps Basic FY 2023 · Dec 31, 2022 −$0.19
Sga Expense FY 2023 · Dec 31, 2022 $5.86M
Rd Expense FY 2023 · Dec 31, 2022 $1.33M
Net Income FY 2023 · Dec 31, 2022 −$1.08M
Operating Income FY 2023 · Dec 31, 2022 −$1.08M
Gross Profit FY 2023 · Dec 31, 2022 $9.29M
Cost Of Revenue FY 2023 · Dec 31, 2022 $15.95M
Stockholders Equity FY 2023 · Dec 31, 2021 $12.24M